Dishman Pharmaceuticals & Chemicals Ltd. - Research Center
532526 DISHMAN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 12 | Mar ' 11 | Mar ' 10 | Mar ' 09 | Mar ' 08 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 16.14 | 16.14 | 16.14 | 16.14 | 15.94 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 658.80 | 623.51 | 594.59 | 532.96 | 436.07 |
| Loan funds | |||||
| Secured loans | 393.96 | 467.80 | 378.92 | 232.19 | 206.19 |
| Unsecured loans | 35.73 | 93.87 | 55.15 | 58.33 | 56.32 |
| Total | 1,104.63 | 1,201.32 | 1,044.79 | 839.62 | 714.52 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 639.35 | 624.64 | 464.18 | 358.73 | 326.33 |
| Less : revaluation reserve | - | 1.73 | 1.74 | 1.76 | 1.78 |
| Less : accumulated depreciation | 169.02 | 137.86 | 110.34 | 90.13 | 70.70 |
| Net block | 470.32 | 485.05 | 352.10 | 266.84 | 253.86 |
| Capital work-in-progress | 257.34 | 303.61 | 267.64 | 172.96 | 110.62 |
| Investments | 187.06 | 187.14 | 181.99 | 156.37 | 132.51 |
| Net current assets | |||||
| Current assets, loans & advances | 528.27 | 458.31 | 377.02 | 342.28 | 325.96 |
| Less : current liabilities & provisions | 338.36 | 232.79 | 133.96 | 98.84 | 109.05 |
| Total net current assets | 189.91 | 225.52 | 243.06 | 243.44 | 216.91 |
| Miscellaneous expenses not written | - | - | - | - | 0.64 |
| Total | 1,104.63 | 1,201.32 | 1,044.79 | 839.62 | 714.52 |
| Notes: | |||||
| Book value of unquoted investments | 187.05 | 187.13 | 181.98 | 156.36 | 132.50 |
| Market value of quoted investments | 0.08 | 0.10 | 0.07 | 0.05 | 0.01 |
| Contingent liabilities | 111.89 | 107.00 | 111.60 | 67.28 | 399.70 |
| Number of equity sharesoutstanding (Lacs) | 806.97 | 806.97 | 806.97 | 806.97 | 796.84 |
© 2013 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback